Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications-Reference-Cited by-同舟云学术

Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications

Published:2015-08-25 Issue:5 Volume:78 Page:824-830
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Albin Roger L.¹²³⁴,Fisher-Hubbard Amanda⁵,Shanmugasundaram Krithika²,Koeppe Robert A.⁶,Burke James F.¹²³,Camelo-Piragua Sandra⁵,Lieberman Andrew P.⁵,Giordani Bruno⁷,Frey Kirk A.²⁶

Affiliation:

1. Neurology Service & GRECC, VAAAHS; Ann Arbor MI

2. Department of Neurology; University of Michigan; Ann Arbor MI

3. Michigan Alzheimer's Disease Center; Ann Arbor MI

4. University of Michigan Morris K. Udall Center of Excellent for Parkinson's Disease Research; Ann Arbor MI

5. Department of Pathology; University of Michigan; Ann Arbor MI

6. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; University of Michigan; Ann Arbor MI

7. Department of Psychiatry; University of Michigan; Ann Arbor MI

Funder

National Institutes of Health

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.24481/fullpdf

Reference28 articles.

1. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology;Knopman;Neurology,2001

2. Accuracy of the clinical evaluation for frontotemporal dementia;Mendez;Arch Neurol,2007

3. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies;McKeith;Neurology,2000

4. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography;Burke;Brain,2011

5. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging;Albin;J Nucl Med,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging;Insights into Imaging;2023-01-16

2. Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies;The British Journal of Psychiatry;2020-12-23

3. Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis;Frontiers in Aging Neuroscience;2020-09-11

4. Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence;Frontiers in Psychiatry;2020-07-15

5. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia;PLOS ONE;2020-04-22